| pubmed-article:9689985 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9689985 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:9689985 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:9689985 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
| pubmed-article:9689985 | lifeskim:mentions | umls-concept:C1512162 | lld:lifeskim |
| pubmed-article:9689985 | lifeskim:mentions | umls-concept:C0332174 | lld:lifeskim |
| pubmed-article:9689985 | lifeskim:mentions | umls-concept:C0280100 | lld:lifeskim |
| pubmed-article:9689985 | lifeskim:mentions | umls-concept:C0016360 | lld:lifeskim |
| pubmed-article:9689985 | lifeskim:mentions | umls-concept:C0021734 | lld:lifeskim |
| pubmed-article:9689985 | lifeskim:mentions | umls-concept:C0210630 | lld:lifeskim |
| pubmed-article:9689985 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:9689985 | lifeskim:mentions | umls-concept:C0086960 | lld:lifeskim |
| pubmed-article:9689985 | lifeskim:mentions | umls-concept:C0205195 | lld:lifeskim |
| pubmed-article:9689985 | lifeskim:mentions | umls-concept:C0205179 | lld:lifeskim |
| pubmed-article:9689985 | lifeskim:mentions | umls-concept:C1554217 | lld:lifeskim |
| pubmed-article:9689985 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:9689985 | pubmed:dateCreated | 1998-10-14 | lld:pubmed |
| pubmed-article:9689985 | pubmed:abstractText | The hematopoietic growth factor filgrastim has been shown to reduce both chemotherapy-induced myelosuppression and mucosal toxicities. The aim of this study was to conduct four separate pilot trials to determine the maximum-tolerated doses at which interferon alpha (IFN alpha) followed by 5-fluorouracil (5-FU) could be administered in combination with filgrastim support. | lld:pubmed |
| pubmed-article:9689985 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9689985 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9689985 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9689985 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9689985 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9689985 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:9689985 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9689985 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9689985 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9689985 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9689985 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9689985 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9689985 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9689985 | pubmed:issn | 1081-4442 | lld:pubmed |
| pubmed-article:9689985 | pubmed:author | pubmed-author:KarpDD | lld:pubmed |
| pubmed-article:9689985 | pubmed:author | pubmed-author:AtkinsMM | lld:pubmed |
| pubmed-article:9689985 | pubmed:author | pubmed-author:NeubergDD | lld:pubmed |
| pubmed-article:9689985 | pubmed:author | pubmed-author:WadlerSS | lld:pubmed |
| pubmed-article:9689985 | pubmed:author | pubmed-author:DutcherJ PJP | lld:pubmed |
| pubmed-article:9689985 | pubmed:author | pubmed-author:HaynesHH | lld:pubmed |
| pubmed-article:9689985 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9689985 | pubmed:volume | 4 | lld:pubmed |
| pubmed-article:9689985 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9689985 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9689985 | pubmed:pagination | 261-8 | lld:pubmed |
| pubmed-article:9689985 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:9689985 | pubmed:meshHeading | pubmed-meshheading:9689985-... | lld:pubmed |
| pubmed-article:9689985 | pubmed:meshHeading | pubmed-meshheading:9689985-... | lld:pubmed |
| pubmed-article:9689985 | pubmed:meshHeading | pubmed-meshheading:9689985-... | lld:pubmed |
| pubmed-article:9689985 | pubmed:meshHeading | pubmed-meshheading:9689985-... | lld:pubmed |
| pubmed-article:9689985 | pubmed:meshHeading | pubmed-meshheading:9689985-... | lld:pubmed |
| pubmed-article:9689985 | pubmed:meshHeading | pubmed-meshheading:9689985-... | lld:pubmed |
| pubmed-article:9689985 | pubmed:meshHeading | pubmed-meshheading:9689985-... | lld:pubmed |
| pubmed-article:9689985 | pubmed:meshHeading | pubmed-meshheading:9689985-... | lld:pubmed |
| pubmed-article:9689985 | pubmed:meshHeading | pubmed-meshheading:9689985-... | lld:pubmed |
| pubmed-article:9689985 | pubmed:meshHeading | pubmed-meshheading:9689985-... | lld:pubmed |
| pubmed-article:9689985 | pubmed:meshHeading | pubmed-meshheading:9689985-... | lld:pubmed |
| pubmed-article:9689985 | pubmed:meshHeading | pubmed-meshheading:9689985-... | lld:pubmed |
| pubmed-article:9689985 | pubmed:meshHeading | pubmed-meshheading:9689985-... | lld:pubmed |
| pubmed-article:9689985 | pubmed:meshHeading | pubmed-meshheading:9689985-... | lld:pubmed |
| pubmed-article:9689985 | pubmed:meshHeading | pubmed-meshheading:9689985-... | lld:pubmed |
| pubmed-article:9689985 | pubmed:articleTitle | Clinical trial of weekly intensive therapy with 5-fluorouracil on two different schedules combined with interferon alpha-2a and filgrastim in patients with advanced solid tumors: Eastern Cooperative Oncology Group Study P-Z991. | lld:pubmed |
| pubmed-article:9689985 | pubmed:affiliation | Albert Einstein Cancer Center, Bronx, New York, USA. | lld:pubmed |
| pubmed-article:9689985 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9689985 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:9689985 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:9689985 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:9689985 | pubmed:publicationType | Multicenter Study | lld:pubmed |
